Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02543281 · ClinicalTrials.gov registry record · NA
Adaptive CRT Effect on Electrical Dyssynchrony
A NA study, sponsored by Larisa Tereshchenko.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02543281 is a NA study that has completed, run by Larisa Tereshchenko. The registered enrollment target is 32 participants.
The verdict
NCT02543281, a NA study, has completed, sponsored by Larisa Tereshchenko.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand how adaptive cardiac resynchronization therapy (aCRT) might benefit patients. aCRT works by sometimes giving stimulation to only the left side of the heart, rather than to both sides, depending on how it senses the heart is functioning. CRT without the adaptive algorithm works by giving stimulation to both sides of the heart. aCRT has already been approved by the FDA and is being used in patients now, but it is not clear which patients it should be used in compared to normal CRT. This study will include patients who are already scheduled to get a CRT device. The investigators will then randomize patients to the aCRT study arm or to the CRT study arm. After 6 months, the investigators will assess the electrical activity of the patients' hearts. After this time, the patient and their doctors will be able to decide if they would like to change the type CRT they have been designated.
Interventions
- DEVICE Adaptive cardiac resynchronization therapy
- DEVICE Conventional Cardiac Resynchronization Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-04 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02543281
The ClinicalTrials.gov registry entry for NCT02543281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Larisa Tereshchenko, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adaptive cardiac resynchronization therapy is the first listed.
NCT02543281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02543281 about?
NCT02543281 is a clinical study titled "Adaptive CRT Effect on Electrical Dyssynchrony". The purpose of this study is to better understand how adaptive cardiac resynchronization therapy (aCRT) might benefit patients. aCRT works by sometimes giving stimulation to only the left side of the heart, rather than to both sides, depending on how it senses the heart is functioning. CRT without t...
What is the current status of trial NCT02543281?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-04. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT02543281?
The interventions under investigation include: Adaptive cardiac resynchronization therapy (DEVICE), Conventional Cardiac Resynchronization Therapy (DEVICE).
Who is sponsoring clinical trial NCT02543281?
This trial is sponsored by Larisa Tereshchenko, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.